Lung Cancers Today Videos
Advertisement
The trial is evaluating perioperative pembrolizumab plus sacituzumab govitecan for certain patients with NSCLC.
Dr. Li discusses important thoracic oncology data presented at the ESMO 2024 Congress, which was held in Barcelona, Spain
Ken Culver, MD, Director of Research and Clinical Affairs at ALK Positive, discusses the on-going ALK Life Study.
Benjamin Besse, MD, PhD, shares insights from the research he presented as a late-breaking abstract at ESMO 2024.
Dr. Halmos weighs in on HARMONi-2, TROPION-Lung 01, the SOHO-01 and Beamion LUNG-1 studies, and more.
The study evaluated multiple prophylactic strategies to mitigate infusion-related reactions with IV amivantamab.
Martin Reck, MD, PhD, shares his insights on key data in lung cancer to be presented at the ESMO Congress 2024.
The studies were highlighted as plenary presentations during a Presidential Symposium at WCLC 2024.
Eric Singhi, MD, and Bruna Pellini, MD, joined Lung Cancers Today at the conference to share their insights on key data.
Narjust Florez, MD, FASCO, discusses meeting highlights, the IASLC 50th Anniversary Celebration, research, and more.
Shirish M. Gadgeel, MD, discusses his presentation on the updated data, with a median follow-up of 31.1 months.
Dr. Reck discusses why the research represents important progress in treating patients with extensive-stage SCLC.
Eric Singhi, MD, shares what he's most looking forward to at the upcoming ISALC 2024 World Conference on Lung Cancer.
Eric Singhi, MD, discusses the key milestone that will be celebrated at the conference, which will be held in San Diego.
Learn how clinicians can take practical steps to ensure patients with lung cancer receive comprehensive biomarker testing.
Recent data show that less than half of patients are receiving biomarker testing results before starting treatment.
Dr. Paz-Ares shares his insights on recent studies and highlights practice-changing data in lung cancer.
A panel of experts shares their insights on key developments and advances in lung cancer treatment research.
Experts discuss important management considerations and the importance of working with a multidisciplinary team.
The panel discusses key questions about NSCLC treatment regimens and the research that could answer them.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.